Dr Reddy's Laboratories News
The generic drugmaker released a statement on social media saying the anti-COVID remedy oral drug 2DG has not yet been launched into the market. Here, we advise our readers to remain vigilant and refrain themselves from falling into the trap of black marketers who lure them by offering the 2DG drug in exchange for a hefty amount. We request you to share this article with your friends and relative so as to alert your surroundings.
Dr Reddy's Laboratories has collaborated with The Russian Direct Investment Fund (RDIF) to conduct clinical trials of the Sputnik V vaccine as well as its distribution. Sputnik V is also the first vaccine candidate in the world to attain regulatory approval. Sputnik V, which was developed by Gamaleya Institute in Moscow, was licensed for use in Russia in August.